Copyrightⓒ2014
SBI Investment KOREA.
All right reserved.
SBI Investment KOREA.
All right reserved.
EQUIPPED WITH 110
YEARS OF ACCUMULATIVE
EXPERIENCE.
-
TaeYoung LeeTeam Manager / Venture Investment Division IV at SBI Investment KOREA
- Profile
-
KB Securities Senior Researcher of Pharmaceuticals/Bio
Meritz Securities Senior Researcher on Pharmaceuticals/Bio
MR. Korea Astellas Pharmaceutical Co., Ltd.
College of Pharmacy at Hanyang University (Pharm. D.)
Korea University Completed in Environmental Health
- In charge of funds
-
□ Co-lead
- SBI-KIS 2022 BIC(Best-In-Class) 3 Fund(21.5 billion KRW)
- Introduction of message
-
Team Manager Lee Tae-young joined SBI Investment KOREA based on his extensive knowledge of the industry and solid financial capabilities he has accumulated through his activities as a pharmaceutical/bio analyst.
We are interested in discovering technologies that will play an active role in the center of next-generation medical services such as the New Drug Development Platform and Digital Health.